Symptoms of dengue by serotype in both primary and secondary cases in the PDCS and PDHS combined, Managua, 2004–2024.

Symptoms of dengue by serotype in both primary and secondary cases in the PDCS and PDHS combined, Managua, 2004–2024.

<p>Symptoms of dengue by serotype in both primary and secondary cases in the PDCS and PDHS combined, Managua, 2004–2024.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Federico Narvaez (197554) (author)
مؤلفون آخرون:	Carlos Montenegro (2887661) (author), Jose G. Juarez (5937815) (author), José Victor Zambrana (5324849) (author), Karla Gonzalez (404055) (author), Elsa Videa (365296) (author), Sonia Arguello (5324852) (author), Fanny Barrios (20543004) (author), Sergio Ojeda (2847896) (author), Miguel Plazaola (5324855) (author), Nery Sanchez (2847887) (author), Daniel Camprubí-Ferrer (11711184) (author), Guillermina Kuan (179743) (author), Gabriela Paz Bailey (20543007) (author), Eva Harris (27355) (author), Angel Balmaseda (109173) (author)
منشور في:	2025
الموضوعات:	Medicine Microbiology Molecular Biology Biotechnology Immunology Cancer Science Policy Infectious Diseases Virology Mathematical Sciences not elsewhere classified low platelet count findings demonstrate differences pediatric clinical studies 17 years old similar disease severity pediatric dengue hospital severe disease compared whereas denv3 caused nicaragua </ p severe disease hospital stay denv3 caused dengue severity clinical manifestations 19 years severity classification dengue vaccine dengue cases xlink "> virological methods pleural effusion increased odds immune status higher proportion greatest percentage denv3 cases denv infection critical need balanced effectiveness 833 participants 644 cases 559 corresponded 21 %) 2009 classification
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!